S 3741
Biosecurity Modernization and Innovation Act of 2026
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:00 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Biosecurity Modernization and Innovation Act of 2026 aims to strengthen the United States’ ability to manage the risks associated with rapidly advancing biotechnology, particularly in the area of gene synthesis. It requires the Commerce Secretary to establish regulations for screening nucleic acid synthesis providers, verifying customer identities, and maintaining a list of ‘sequences of concern’ to prevent misuse. The bill also establishes a biotechnology governance sandbox and directs a review of existing biosecurity and biosafety authorities across the federal government to streamline oversight and improve efficiency.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.